US Broker Ratings

Apellis Pharmaceuticals (APLS) Stock Analysis: A 40% Upside Potential for Investors

Investors in the biotechnology sector are always on the lookout for promising opportunities, and Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) is garnering significant attention. With a market..

Zai Lab Limited (ZLAB): Investor Outlook and 92.79% Upside Potential in the Biotech Sector

Zai Lab Limited (NASDAQ: ZLAB), a prominent player in the biotechnology sector, offers investors an intriguing opportunity with a potential upside of 92.79%. Headquartered in Pudong,..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Navigating Growth with a 49% Revenue Surge

Alignment Healthcare, Inc. (NASDAQ: ALHC) is making waves in the healthcare industry with its innovative approach to senior care. Operating a consumer-centric platform, it focuses on..

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 47.81% Potential Upside in the Healthcare Sector

Surgery Partners, Inc. (NASDAQ: SGRY) stands out in the healthcare sector with a promising growth trajectory underscored by a significant potential upside of 47.81%. As a..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: A Biotech Hopeful with a 4% Upside Potential

For investors seeking opportunities in the biotechnology sector, Akero Therapeutics, Inc. (NASDAQ: AKRO) presents a compelling case. With a market capitalization of $4.32 billion and a..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Navigating Market Challenges with a 2% Upside Potential

Bausch + Lomb Corporation (NYSE: BLCO), a venerable name in the healthcare sector, is a key player in the medical instruments and supplies industry, specializing in..

Vaxcyte, Inc. (PCVX) Stock Analysis: Unveiling a 131% Potential Upside in Biotech

Vaxcyte, Inc. (PCVX), a pioneering company in the biotechnology sector, is capturing attention with its ambitious vaccine development pipeline and significant potential upside. Headquartered in San..

Glaukos Corporation (GKOS) Stock Analysis: A 34.79% Potential Upside Amid Robust Revenue Growth

Investors with a keen eye on the healthcare sector may find Glaukos Corporation (NYSE: GKOS) an intriguing opportunity, especially considering its potential upside of 34.79% based..

Integer Holdings Corporation (ITGR)

⚠️ No article content returned.

..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Investors Eye 39% Potential Upside with Strong Buy Ratings

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a leading biopharmaceutical player in the biotechnology sector, has captured significant attention from investors due to its impressive growth trajectory and..

BrightSpring Health Services, I (BTSG): Investor Outlook on a 7.64% Upside Potential

BrightSpring Health Services, Inc. (NASDAQ: BTSG), a major player in the healthcare sector, presents an intriguing opportunity for investors seeking exposure to the dynamic field of..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: Exploring the 16.75% Upside Potential

Madrigal Pharmaceuticals, Inc. (MDGL), a promising player in the biotechnology sector, has captured the attention of investors with its compelling narrative centered on innovative treatments for..

Avidity Biosciences, Inc. (RNA) Investor Outlook: Strong Buy Ratings Signal 42% Upside Potential

Avidity Biosciences, Inc. (RNA), a promising player in the biotechnology sector, is making waves among investors with its innovative approach to tackling diseases through RNA therapeutics...

Telix Pharmaceuticals Limited (TLX): Investor Outlook with 93% Potential Upside

Telix Pharmaceuticals Limited (TLX), an emerging player in the biotechnology sector, has captured the attention of investors with its robust growth potential and a promising pipeline..

Sarepta Therapeutics (SRPT) Stock Analysis: Biotechnology Innovator with a 3.92% Potential Upside

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a leading player in the biopharmaceutical space, continues to capture investor attention with its pioneering work in RNA-targeted therapeutics and gene..

Option Care Health, Inc. (OPCH) Investor Outlook: Unlocking a 38% Upside Potential

Option Care Health, Inc. (NASDAQ: OPCH), a leading provider of home and alternate site infusion services in the United States, is capturing the attention of investors..

Guardant Health, Inc. (GH) Stock Analysis: Navigating Growth in Precision Oncology with 6% Upside Potential

Guardant Health, Inc. (NASDAQ: GH) is a key player in the healthcare sector, specifically within the diagnostics and research industry. This precision oncology company, headquartered in..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Look at Its 11.71% Potential Upside and Strong Buy Consensus

Krystal Biotech, Inc. (NASDAQ: KRYS) is capturing the attention of investors with its innovative approach to genetic medicine and a promising growth trajectory in the biotechnology..

ADMA Biologics Inc (ADMA) Stock Analysis: Eyeing Nearly 94% Potential Upside with Strong Analyst Confidence

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology sector, is drawing attention from investors with its compelling growth metrics and robust market presence..

Alkermes plc (ALKS) Stock Analysis: A Promising 38% Upside in the Healthcare Sector

Alkermes plc (NASDAQ: ALKS), a leading biopharmaceutical company headquartered in Dublin, Ireland, is capturing investor interest with a potential 38.02% upside, as suggested by current analyst..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds